Cargando…

A Case Study of European Collaboration between the Veterinary and Human Field for the Development of RSV Vaccines

The One Health (OH) approach describes the interconnection between the health of animals, humans, and the environment. The need for collaboration between the veterinary and human fields is increasing due to the rise in several infectious diseases that cross human–animal barriers and need to be addre...

Descripción completa

Detalles Bibliográficos
Autores principales: Janse, Marga, Sesa, Giulia, van de Burgwal, Linda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385505/
https://www.ncbi.nlm.nih.gov/pubmed/37514953
http://dx.doi.org/10.3390/vaccines11071137
_version_ 1785081424275046400
author Janse, Marga
Sesa, Giulia
van de Burgwal, Linda
author_facet Janse, Marga
Sesa, Giulia
van de Burgwal, Linda
author_sort Janse, Marga
collection PubMed
description The One Health (OH) approach describes the interconnection between the health of animals, humans, and the environment. The need for collaboration between the veterinary and human fields is increasing due to the rise in several infectious diseases that cross human–animal barriers and need to be addressed jointly. However, such collaboration is not evident in practice, especially for non-zoonotic diseases. A qualitative research approach was used to explore the barriers and enablers influencing collaborative efforts on the development of vaccines for the non-zoonotic RSV virus. It was found that in the European context, most veterinary and human health professionals involved in RSV vaccine development see themselves as belonging to two distinct groups, indicating a lack of a common goal for collaboration. Next to this, the different conceptualizations of the OH approach, and the fact that RSV is not a zoonotic disease, strengthens the opinion that there is no shared need for collaboration. This paper adds insights on how, for a non-zoonotic situation, collaboration between human and veterinary professionals shaped the development of vaccines in both areas; thus, improving public health requires awareness, mutual appreciation, and shared goal setting.
format Online
Article
Text
id pubmed-10385505
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-103855052023-07-30 A Case Study of European Collaboration between the Veterinary and Human Field for the Development of RSV Vaccines Janse, Marga Sesa, Giulia van de Burgwal, Linda Vaccines (Basel) Article The One Health (OH) approach describes the interconnection between the health of animals, humans, and the environment. The need for collaboration between the veterinary and human fields is increasing due to the rise in several infectious diseases that cross human–animal barriers and need to be addressed jointly. However, such collaboration is not evident in practice, especially for non-zoonotic diseases. A qualitative research approach was used to explore the barriers and enablers influencing collaborative efforts on the development of vaccines for the non-zoonotic RSV virus. It was found that in the European context, most veterinary and human health professionals involved in RSV vaccine development see themselves as belonging to two distinct groups, indicating a lack of a common goal for collaboration. Next to this, the different conceptualizations of the OH approach, and the fact that RSV is not a zoonotic disease, strengthens the opinion that there is no shared need for collaboration. This paper adds insights on how, for a non-zoonotic situation, collaboration between human and veterinary professionals shaped the development of vaccines in both areas; thus, improving public health requires awareness, mutual appreciation, and shared goal setting. MDPI 2023-06-23 /pmc/articles/PMC10385505/ /pubmed/37514953 http://dx.doi.org/10.3390/vaccines11071137 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Janse, Marga
Sesa, Giulia
van de Burgwal, Linda
A Case Study of European Collaboration between the Veterinary and Human Field for the Development of RSV Vaccines
title A Case Study of European Collaboration between the Veterinary and Human Field for the Development of RSV Vaccines
title_full A Case Study of European Collaboration between the Veterinary and Human Field for the Development of RSV Vaccines
title_fullStr A Case Study of European Collaboration between the Veterinary and Human Field for the Development of RSV Vaccines
title_full_unstemmed A Case Study of European Collaboration between the Veterinary and Human Field for the Development of RSV Vaccines
title_short A Case Study of European Collaboration between the Veterinary and Human Field for the Development of RSV Vaccines
title_sort case study of european collaboration between the veterinary and human field for the development of rsv vaccines
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385505/
https://www.ncbi.nlm.nih.gov/pubmed/37514953
http://dx.doi.org/10.3390/vaccines11071137
work_keys_str_mv AT jansemarga acasestudyofeuropeancollaborationbetweentheveterinaryandhumanfieldforthedevelopmentofrsvvaccines
AT sesagiulia acasestudyofeuropeancollaborationbetweentheveterinaryandhumanfieldforthedevelopmentofrsvvaccines
AT vandeburgwallinda acasestudyofeuropeancollaborationbetweentheveterinaryandhumanfieldforthedevelopmentofrsvvaccines
AT jansemarga casestudyofeuropeancollaborationbetweentheveterinaryandhumanfieldforthedevelopmentofrsvvaccines
AT sesagiulia casestudyofeuropeancollaborationbetweentheveterinaryandhumanfieldforthedevelopmentofrsvvaccines
AT vandeburgwallinda casestudyofeuropeancollaborationbetweentheveterinaryandhumanfieldforthedevelopmentofrsvvaccines